"Integrum is currently undergoing a major strategic shift. As part of this work, the board has renegotiated Acting CEO Scott Flora's compensation package to increase focus on performance-based compensation. The recruitment of a permanent CEO is ongoing, and the new agreement with Scott Flora provides continued stability and growth focus in the executive management team during this transition phase," comments Kristofer Westergren, Board Director of Integrum and coordinator of the business assessment and strategic shift. 

The new incentive program is based on Stock Appreciation Rights ("SARs") for the Board Member and Acting CEO Scott Flora. Within the framework of the program, Scott Flora has been granted 200,000 SARs, where each vested SAR entitles to a compensation based on Integrum's share price, but not exceeding SEK 60, on the day of exercise of the vested SARs, less an exercise price (so-called Base Price) amounting to SEK 29.30 per SAR. The granted SARs will vest at a rate of 20 percent every three months starting from June 1, 2025. Unvested SARs will lapse and will not entitle the holder to any payment. A vested SAR shall be exercisable during 1 September 2026 to 31 October 2026. The SAR payment may be paid in stock or in cash, at the Integrums election.

In connection with the new incentive program taking effect, the fixed compensation to Scott Flora will be reduced. The incentive program falls within the framework of the guidelines for compensation to senior executives adopted at Integrum's most recent shareholders' meeting.